502 related articles for article (PubMed ID: 28365007)
1. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization.
Cieslak KP; Huisman F; Bais T; Bennink RJ; van Lienden KP; Verheij J; Besselink MG; Busch ORC; van Gulik TM
Surgery; 2017 Jul; 162(1):37-47. PubMed ID: 28365007
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function.
Olthof PB; Tomassini F; Huespe PE; Truant S; Pruvot FR; Troisi RI; Castro C; Schadde E; Axelsson R; Sparrelid E; Bennink RJ; Adam R; van Gulik TM; de Santibanes E
Surgery; 2017 Oct; 162(4):775-783. PubMed ID: 28732555
[TBL] [Abstract][Full Text] [Related]
3. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
Chan ACY; Chok K; Dai JWC; Lo CM
Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS.
Lunardi A; Cervelli R; Volterrani D; Vitali S; Lombardo C; Lorenzoni G; Crocetti L; Bargellini I; Campani D; Pollina LE; Cioni R; Caramella D; Boggi U
Cardiovasc Intervent Radiol; 2018 May; 41(5):789-798. PubMed ID: 29359240
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
[TBL] [Abstract][Full Text] [Related]
6. Nonsuperiority of technetium-99m-galactosyl human serum albumin scintigraphy over conventional volumetry for assessing the future liver remnant in patients undergoing hepatectomy after portal vein embolization.
Yao S; Taura K; Yoh T; Nishio T; Koyama Y; Ogiso S; Okamoto T; Fukumitsu K; Ishii T; Seo S; Hata K; Masui T; Shimizu H; Ishimori T; Hatano E
Surgery; 2023 Feb; 173(2):435-441. PubMed ID: 36372575
[TBL] [Abstract][Full Text] [Related]
7. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?
Chia DKA; Yeo Z; Loh SEK; Iyer SG; Bonney GK; Madhavan K; Kow AWC
Am J Surg; 2018 Jan; 215(1):131-137. PubMed ID: 28859921
[TBL] [Abstract][Full Text] [Related]
8. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
[TBL] [Abstract][Full Text] [Related]
9. [Portal vein embolization: Present and future].
Piron L; Deshayes E; Escal L; Souche R; Herrero A; Pierredon-Foulongne MA; Assenat E; le Lam N; Quenet F; Guiu B
Bull Cancer; 2017 May; 104(5):407-416. PubMed ID: 28477870
[TBL] [Abstract][Full Text] [Related]
10. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
[TBL] [Abstract][Full Text] [Related]
11. Contribution of hepatobiliary scintigraphy in assessing ALPPS most suited timing.
Truant S; Baillet C; Deshorgue AC; El Amrani M; Huglo D; Pruvot FR
Updates Surg; 2017 Sep; 69(3):411-419. PubMed ID: 28795384
[TBL] [Abstract][Full Text] [Related]
12. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.
Leung U; Simpson AL; Araujo RL; Gönen M; McAuliffe C; Miga MI; Parada EP; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Fong Y; Jarnagin WR
J Am Coll Surg; 2014 Oct; 219(4):620-30. PubMed ID: 25158914
[TBL] [Abstract][Full Text] [Related]
13. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
Zhang GQ; Zhang ZW; Lau WY; Chen XP
Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
[TBL] [Abstract][Full Text] [Related]
14. Chance and challenge of associating liver partition and portal vein ligation for staged hepatectomy.
Xiang F; Hu ZM
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):214-222. PubMed ID: 31056484
[TBL] [Abstract][Full Text] [Related]
15. Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study.
Chapelle T; Op de Beeck B; Roeyen G; Bracke B; Hartman V; De Greef K; Huyghe I; Van der Zijden T; Morrison S; Francque S; Ysebaert D
HPB (Oxford); 2017 Feb; 19(2):108-117. PubMed ID: 27956027
[TBL] [Abstract][Full Text] [Related]
16. Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response.
Rassam F; Olthof PB; van Lienden KP; Bennink RJ; Besselink MG; Busch OR; van Gulik TM
Surgery; 2019 Apr; 165(4):686-695. PubMed ID: 30573191
[TBL] [Abstract][Full Text] [Related]
17. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection.
de Graaf W; van Lienden KP; Dinant S; Roelofs JJ; Busch OR; Gouma DJ; Bennink RJ; van Gulik TM
J Gastrointest Surg; 2010 Feb; 14(2):369-78. PubMed ID: 19937195
[TBL] [Abstract][Full Text] [Related]
18. [Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) - new opportunity in two-stage liver resection in patients with colorectal cancer metastases].
Skipenko OG; Chardarov NK; Bagmet NN; Bedzhanian AL; Polishchuk LO; Shatverian GA
Khirurgiia (Mosk); 2014; (9):23-9. PubMed ID: 25327741
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy.
Hasselgren K; Malagò M; Vyas S; Campos RR; Brusadin R; Linecker M; Petrowsky H; Clavien PA; Machado MA; Hernandez-Alejandro R; Wanis K; Valter L; Sandström P; Björnsson B
Surgery; 2017 May; 161(5):1255-1265. PubMed ID: 28081953
[TBL] [Abstract][Full Text] [Related]
20. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.
Theilig D; Steffen I; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T; Geisel D
Eur Radiol; 2019 Nov; 29(11):5861-5872. PubMed ID: 30899977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
